1,796 material Form 8-K filings that 1,448 companies we cover made with the SEC in May 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Cencora appointed Eva C. Boratto, currently CFO of Bath & Body Works, as Executive Vice President and Chief Financial Officer, effective June 29, 2026, succeeding James F. Cleary, who is retiring and will advise through the end of 2026. The company also reaffirmed its fiscal 2026 adjusted diluted EPS guidance of $17.70 to $17.90 and its long-term growth targets.
Eva C. Boratto succeeds James F. Cleary as CFO, effective June 29, 2026; Cleary serves in an advisory role through the end of 2026
Boratto's compensation includes a $1,000,000 base salary, a 100% annual bonus target, a $2,000,000 one-time sign-on bonus, and a $6,000,000 restricted stock unit award
Fiscal 2026 adjusted diluted EPS guidance of $17.70 to $17.90 was reaffirmed; it was previously updated on May 21, 2026 from $17.65 to $17.90 after share repurchases
Seacoast Banking Corporation of Florida disclosed that director H. Gilbert Culbreth Jr. notified the company on May 27, 2026, of his decision to resign from its Board of Directors, effective June 15, 2026. He will remain on the board of its principal operating subsidiary, Seacoast National Bank, and the company said the resignation was for personal reasons and not due to any disagreement.
Resignation notified May 27, 2026; effective June 15, 2026
Culbreth was appointed to the Company's Board in 2008 and sat on the compensation and governance committee
Culbreth will remain on the board of Seacoast National Bank
Company states the resignation was for personal reasons and not a result of any disagreement
ScanSource notified Rachel Hayden, its Senior Executive Vice President and Chief Information Officer, on May 22, 2026 that her role will be eliminated effective June 8, 2026. She is entitled to severance under the company's Executive Severance Plan and is subject to restrictive covenants in that plan, and the filing gives no replacement or financial figures.
Role of Senior Executive Vice President and Chief Information Officer eliminated effective June 8, 2026
Company notified Rachel Hayden on May 22, 2026
Hayden entitled to severance under the Executive Severance Plan, with non-compete and non-solicitation terms
Filing does not state a severance amount or a successor
Averin Capital Acquisition Corp., a special purpose acquisition company (SPAC), appointed Akiko Moni Miyashita to its board effective immediately on May 28, 2026. She is a former Valo Health and IBM corporate strategy and M&A executive, and she signed a joinder to the company's February 18, 2026 letter agreement, which includes redemption waivers and voting commitments for an initial business combination.
Board appointment made May 28, 2026, effective immediately; Ms. Miyashita will serve in the first class of directors until the first annual general meeting.
Ms. Miyashita, age 70, is founder of Beacon Hill Strategy Group and previously served as Executive Vice President and Chief Strategy Officer of Valo Health, LLC (May 2019 to September 2024).
She signed a joinder to the February 18, 2026 letter agreement, under which signatories agreed to waive certain redemption rights and vote in favor of an initial business combination.
She also signed a joinder to the February 18, 2026 registration rights agreement and entered into a standard director indemnity agreement.
Three directors, Patricia L. Moss, David L. Jahnke and Stephen M. Lacy, were deemed to have retired on May 27, 2026, under the company's director retirement age policy of 72, and the board was reduced from 14 to 11 seats. Shareholders also approved a charter amendment, effective May 28, 2026, that applies a plurality voting standard to contested director elections while keeping majority voting for uncontested elections.
Moss, Jahnke and Lacy were deemed retired and resigned from the board on May 27, 2026, before the 2026 annual meeting; the company said none of the retirements involved a disagreement with the company.
Board size was reduced from 14 to 11 directors, with each class reduced to avoid vacancies.
Shareholders approved the charter amendment: 72,701,511 for and 1,281,015 against; it took effect with a filing on May 28, 2026.
Shareholders voted on the auditor: Ernst & Young LLP was ratified for fiscal 2026 with 79,488,279 votes for and 233,150 against.
On May 29, 2026, KKR & Co. Inc. disclosed that KKR Management LLP elected 11 named individuals to its Board of Directors under Section 3.02 of the company's bylaws. Each was already serving as a director at the time of election, so the filing describes a formal confirmation rather than a change in board membership.
Election date: May 29, 2026, by KKR Management LLP under Section 3.02 of the Amended and Restated Bylaws
Directors named include Henry R. Kravis, George R. Roberts, Joseph Y. Bae, Scott C. Nuttall and Patricia F. Russo
Non-employee directors continue to receive compensation under the existing program described in the 2025 Form 10-K
The filing does not report any shareholder vote results under Item 5.07
Avis Budget Group appointed Tina Goldenberg as Vice President and Chief Accounting Officer, effective June 15, 2026, succeeding Cathleen DeGenova, who is retiring. DeGenova remains Senior Vice President and Chief Accounting Officer until June 14, 2026, and will advise the company through April 1, 2027. The change is a routine succession in a finance role and does not alter reported results.
Tina Goldenberg, age 42, appointed Vice President and Chief Accounting Officer, effective June 15, 2026
Goldenberg's offer letter sets an annual base salary of $270,000 and a target annual incentive of 45% of base salary
Cathleen DeGenova, who is retiring after 13 years, serves until June 14, 2026 and advises through April 1, 2027
LENSAR's Board appointed Michael A. Rossi as Interim Chief Financial Officer and principal financial officer, effective May 29, 2026. Rossi will serve through a consulting agreement with Monomoy Advisors LLC at a $375 per hour cash retainer. The company also set its 2026 annual meeting for August 4, 2026, and moved the deadlines for stockholder proposals and nominations to June 8, 2026.
Michael A. Rossi appointed Interim CFO and principal financial officer by the Board on May 25, 2026, effective May 29, 2026
Rossi is provided through Monomoy Advisors LLC under a consulting agreement at a $375 per hour cash retainer
2026 annual meeting scheduled for August 4, 2026, to be held virtually; record date is June 10, 2026
Deadline for stockholder proposals, director nominations and Rule 14a-19 notices is June 8, 2026
Jazz Pharmaceuticals said Class III director Anne O'Riordan told the board on May 25, 2026 that she will not stand for re-election at the 2026 annual meeting of shareholders. The company said her decision was not the result of any dispute or disagreement with the company or the board on its operations, policies or practices, and that the board will continue to evaluate its composition and manage orderly succession.
Anne O'Riordan, a Class III director, informed the board on May 25, 2026 that she will not stand for re-election.
Her term expires at the 2026 annual meeting of shareholders.
The company said the departure was not due to any dispute or disagreement with the company or board.
The filing was signed by Neena Patil, Executive Vice President and Chief Legal Officer, on May 29, 2026.
Chevron said its Chief Legal Officer, R. Hewitt Pate, notified the board on May 27, 2026 that he will resign effective December 31, 2026, ahead of his expected retirement in June 2027. Pate will stay on as a non-executive senior advisor through retirement to help transition his duties, so the change is planned and gradual.
R. Hewitt Pate resigns as Chief Legal Officer, effective December 31, 2026
Notice to the board was given on May 27, 2026
Expected retirement in June 2027; Pate remains as non-executive senior advisor until then
Apogee Enterprises disclosed that Brent C. Jewell resigned as President of its Architectural Glass Segment on May 26, 2026, with his last day set for June 10, 2026. The company says the resignation is unrelated to the transaction it announced on May 28, 2026, and was not due to any disagreement with the company; Jewell will support transition and integration work for that transaction until his departure.
Brent C. Jewell resigned as President of the Architectural Glass Segment on May 26, 2026.
His last day with the company will be June 10, 2026.
The company states the resignation is unrelated to the transaction announced May 28, 2026, and involved no disagreement on operations, policies or practices.
Jewell is expected to assist with transition, pre-closing and integration activities for that transaction through his final day.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.